Spire Wealth Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.8K Hold
30
– – ﹤0.01% 1768
2026
Q2
$3.09K Hold
30
– – ﹤0.01% 1917
2026
Q1
$1.43K Hold
30
– – ﹤0.01% 2091
2025
Q4
$952 Hold
30
– – ﹤0.01% 2202
2025
Q3
$844 Hold
30
– – ﹤0.01% 2298
2025
Q2
$1.1K Hold
30
– – ﹤0.01% 2265
2025
Q1
$1.18K Hold
30
– – ﹤0.01% 2362
2024
Q4
$1.39K Hold
30
– – ﹤0.01% 2316
2024
Q3
$1.36K Hold
30
– – ﹤0.01% 2060
2024
Q2
$1.48K Hold
30
– – ﹤0.01% 2059
2024
Q1
$1.03K Hold
30
– – ﹤0.01% 2201
2023
Q4
$1.01K Hold
30
– – ﹤0.01% 2264
2023
Q3
$608 Hold
30
– – ﹤0.01% 2326
2023
Q2
$614 Buy
+30
New +$449 ﹤0.01% 2361
2023
Q1
– Sell
-30
Closed -$1K – 2599
2022
Q4
$1K Hold
30
– – ﹤0.01% 2259
2022
Q3
$1K Hold
30
– – ﹤0.01% 2143
2022
Q2
$1K Hold
30
– – ﹤0.01% 2584
2022
Q1
$1K Sell
30
-200
-87% -$11.1K ﹤0.01% 2485
2021
Q4
$18K Buy
230
+200
+667% +$20.5K ﹤0.01% 2165
2021
Q3
$3K Hold
30
– – ﹤0.01% 2420
2021
Q2
$4K Hold
30
– – ﹤0.01% 2381
2021
Q1
$4K Buy
+30
New +$4.56K ﹤0.01% 2714

Other funds holding TWST

Spire Wealth Management's TWST Position: Q3 2026 in Review

Spire Wealth Management held its Twist Bioscience (TWST) position steady in Q3 2026 at 30 shares worth $5.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1768.

Spire Wealth Management first reported a position in TWST in Q1 2021 and has held it in 22 quarters since. The position peaked at $18K in Q4 2021. 330 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Spire Wealth Management held 30 shares of Twist Bioscience worth $5.8K as of Q3 2026.
  • Spire Wealth Management left its Twist Bioscience share count unchanged in Q3 2026.
  • Twist Bioscience made up ﹤0.01% of Spire Wealth Management's portfolio in Q3 2026, its #1768 holding.
  • Spire Wealth Management first reported a position in Twist Bioscience in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's Twist Bioscience position peaked at $18K in Q4 2021.
  • 330 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Spire Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.